Workboat Indexes

Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Workboat Indexes
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eyenovia, Inc. - Common Stock (NQ: EYEN )

0.0853 -0.0047 (-5.22%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eyenovia, Inc. - Common Stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Crude Oil Dips Over 2%; Bloom Energy Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline
Eyenovia's Phase 3 CHAPERONE study fails to meet its primary endpoint, prompting a review of strategic alternatives, including potential mergers or asset sales. 
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Earnings Outlook For Eyenovia
Via Benzinga
S&P 500 Down Over 1%; US Retail Sales Top Expectations
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Tumbles Over 200 Points; Alibaba Posts Upbeat Sales
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
EYEN Shares Are Trading Higher Today: What You Need To Know
Eyenovia shares are surging Monday in response to the company's announcement of the launch of a new FDA-approved ophthalmic drug in collaboration with Formosa Pharmaceuticals. 
Via Benzinga
Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?
Eyenovia (stock surges with high trading volume after announcing a $5.14 million offering to fund commercialization of Mydcombi, pediatric myopia research, and debt repayment. 
Via Benzinga
Nasdaq Gains 0.5%; TJX Earnings Top Estimates
Via Benzinga
Crude Oil Down 1%; BigBear.ai Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Why Eyenovia (EYEN) Stock Is Getting Hammered Today
Eyenovia shares are trading lower by 35% Wednesday morning. The company announced plans to sell shares or pre-funded warrants in a best efforts offering. 
Via Benzinga
US Stocks Higher; Target Posts Upbeat Earnings
Via Benzinga
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
EYEN Stock Earnings: Eyenovia Misses EPS, Misses Revenue for Q2 2024
EYEN stock results show that Eyenovia missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Crude Oil Moves Higher; Deere Cuts Profit Outlook
Via Benzinga
Exposures Fossil Fuels
Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
EYEN Stock Earnings: Eyenovia Misses EPS, Misses Revenue for Q1 2024
EYEN stock results show that Eyenovia missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Diversified Communications
© 2024 Diversified Communications. All rights reserved.